中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2015年
8期
1331-1334
,共4页
子宫内膜异位症%免疫组织化学%子宫腺肌瘤%SCF/C-Kit
子宮內膜異位癥%免疫組織化學%子宮腺肌瘤%SCF/C-Kit
자궁내막이위증%면역조직화학%자궁선기류%SCF/C-Kit
Endometriosis%Immunohistochemistry%Adenomyoma%SCF/C-Kit
目的:探讨子宫腺肌瘤和子宫内膜异位症(内异症)患者在位、异位内膜中干细胞因子(SCF)及其C-Kit的表达,从而了解SCF及其受体C-Kit分别在子宫腺肌瘤和内异症发病中的作用。方法采用免疫组化法,检测各组在位内膜及异位内膜组织SCF、C-Kit的表达。结果本研究各组均表达SCF和C-Kit,SCF的表达在研究组中较对照组明显增强,差异均有统计学意义(子宫腺肌瘤组 P<0.01;内异症组 P<0.05),在腺肌病患者中在位内膜分泌期的表达明显增高,分泌期>增生期(P<0.01),在位内膜>异位内膜(P<0.05);在巧克力囊肿患者中,在位内膜分泌期的表达较在位内膜增生期和异位内膜及对照组各期均增高,差异有统计学意义(P<0.05),而较子宫腺肌瘤低,但差异无统计学意义(P>0.05);C-Kit在腺肌病患者中的表达较巧克力囊肿组和对照组增高,差异有统计学意义(P<0.05),在位内膜分泌期的表达较在位内膜增生期和异位内膜及对照组各期均增高,差异有统计学意义(P<0.05)。结论 SCF、C-Kit可能是子宫内膜腺肌瘤和子宫内膜异位症的重要发病原因之一。
目的:探討子宮腺肌瘤和子宮內膜異位癥(內異癥)患者在位、異位內膜中榦細胞因子(SCF)及其C-Kit的錶達,從而瞭解SCF及其受體C-Kit分彆在子宮腺肌瘤和內異癥髮病中的作用。方法採用免疫組化法,檢測各組在位內膜及異位內膜組織SCF、C-Kit的錶達。結果本研究各組均錶達SCF和C-Kit,SCF的錶達在研究組中較對照組明顯增彊,差異均有統計學意義(子宮腺肌瘤組 P<0.01;內異癥組 P<0.05),在腺肌病患者中在位內膜分泌期的錶達明顯增高,分泌期>增生期(P<0.01),在位內膜>異位內膜(P<0.05);在巧剋力囊腫患者中,在位內膜分泌期的錶達較在位內膜增生期和異位內膜及對照組各期均增高,差異有統計學意義(P<0.05),而較子宮腺肌瘤低,但差異無統計學意義(P>0.05);C-Kit在腺肌病患者中的錶達較巧剋力囊腫組和對照組增高,差異有統計學意義(P<0.05),在位內膜分泌期的錶達較在位內膜增生期和異位內膜及對照組各期均增高,差異有統計學意義(P<0.05)。結論 SCF、C-Kit可能是子宮內膜腺肌瘤和子宮內膜異位癥的重要髮病原因之一。
목적:탐토자궁선기류화자궁내막이위증(내이증)환자재위、이위내막중간세포인자(SCF)급기C-Kit적표체,종이료해SCF급기수체C-Kit분별재자궁선기류화내이증발병중적작용。방법채용면역조화법,검측각조재위내막급이위내막조직SCF、C-Kit적표체。결과본연구각조균표체SCF화C-Kit,SCF적표체재연구조중교대조조명현증강,차이균유통계학의의(자궁선기류조 P<0.01;내이증조 P<0.05),재선기병환자중재위내막분비기적표체명현증고,분비기>증생기(P<0.01),재위내막>이위내막(P<0.05);재교극력낭종환자중,재위내막분비기적표체교재위내막증생기화이위내막급대조조각기균증고,차이유통계학의의(P<0.05),이교자궁선기류저,단차이무통계학의의(P>0.05);C-Kit재선기병환자중적표체교교극력낭종조화대조조증고,차이유통계학의의(P<0.05),재위내막분비기적표체교재위내막증생기화이위내막급대조조각기균증고,차이유통계학의의(P<0.05)。결론 SCF、C-Kit가능시자궁내막선기류화자궁내막이위증적중요발병원인지일。
Objective To study the expression of stem cell factor (SCF) and its receptor C-Kit in ectopic and eutopic endometrium in patients with endometrioma and endometriosis, to investigate the effect of SCF and its receptor C-Kit in pathogenesis in the endometrioma and endometriosis. Methods Immunohistochemical method was used to examine the expression of SCF and C-Kit in the eutopic and ectopic endometrium. Results All groups were expressing SCF and C-Kit, but the expression of SCF was enhancer in observation groups than contrast group. These differences were all statistical significance (the group of endometrioma was P<0.01, and the group of endometriosis was P<0.05). The expression of secretory phase in eutopic endometrium of the endometrioma was enhancer, which was greater than proliferative phase (P<0.01), the eutopic endometrium was also greater than ectopic endometrium (P<0.05). In the chocolate cysts, the expression of secretory phase of endometrium was enhancer than proliferative stage of endometrium and ectopic endometrium and every phases of contrast group, which were statistical significance (P<0.05), but it was under than endometrioma, and the differences were not statistical significance (P>0.05). The expression of C-Kit in the adenomyomatosis was higher than chocolate cyst group and contrast group (P<0.05), which was statistical significance. The expression of endometrium in the secretory phase was higher than its proliferative phase and each phase of ectopic endometrium, and contrast group too, which was statistical significance (P<0.05). Conclusion The SCF/C-Kit may play an important role in pathogeny of the adenomyoma and endometriosis.